Research graph
References from Procoagulant effects of extracellular vesicles in patients with livedo reticularis. Local targets link to admitted publications; unresolved targets remain external evidence.
Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches
10.1002/jev2.12404 · 2024 · External reference
Consensus on the management of the clinical challenges of venous thromboembolism in special situations
10.1055/a-2595-1811 · 2025 · External reference
Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome
2005 · External reference
Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis
10.1177/09612033221126852 · 2022 · External reference
Clinical and immunologic features of livedo reticularis in lupus: a case-control study
10.1016/s0002-9343(89)80823-x · 1989 · External reference
Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes
10.1161/01.atv.0000252898.48084.6a · 2007 · External reference
Microparticles in hemostasis and thrombosis
10.1161/circresaha.110.233056 · 2011 · External reference
Characterization of plasma-derived small extracellular vesicles indicates ongoing endothelial and platelet activation in patients with thrombotic antiphospholipid syndrome
10.3390/cells9051211 · 2020 · External reference
Tissue factor activity of small and large extracellular vesicles in different diseases
10.1016/j.rpth.2023.100124 · 2023 · External reference
Novel perspectives on extracellular vesicles in autoimmune diseases: immunogenicity, inflammation, and immune surveillance
10.1172/jci194715 · 2026 · External reference
Extracellular vesicles as orchestrators of arterial and venous thrombosis: a unified mechanistic model
10.1016/j.vph.2026.107605 · 2026 · External reference
Dysregulated pathways and potential biomarkers in dermatomyositis plasma-derived extracellular vesicles: a pilot study
10.1016/j.jid.2025.06.1597 · 2026 · External reference
Extracellular vesicles in the antiphospholipid syndrome
10.1055/s-0037-1599081 · 2018 · External reference
KLF8 transcription factor participates in oncogenic transformation
10.1038/sj.onc.1209796 · 2007 · External reference
Regulation of vascular smooth muscle phenotype by cross-regulation of Krüppel-like factors
10.4196/kjpp.2017.21.1.37 · 2017 · External reference
The Krüppel-like factor (KLF) family, diseases, and physiological events
10.1016/j.gene.2023.148027 · 2024 · External reference
The role of Krüppel-like factor 8 in cancer biology: current research and its clinical relevance
10.1016/j.bcp.2020.114351 · 2021 · External reference
Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma
10.1038/s41598-018-35786-6 · 2018 · External reference
KLF8 is activated by TGF-β1 via Smad2 and contributes to ovarian cancer progression
10.1002/jcb.30235 · 2022 · External reference
Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion
10.1158/0008-5472.can-06-4729 · 2007 · External reference
Krüppel-like factors compete for promoters and enhancers to fine-tune transcription
10.1093/nar/gkx441 · 2017 · External reference
Krüppel-like factor 8 overexpression is correlated with angiogenesis and poor prognosis in gastric cancer
10.3748/wjg.v19.i27.4309 · 2013 · External reference
KLF11 protects against venous thrombosis via suppressing tissue factor expression
10.1055/s-0041-1735191 · 2022 · External reference
Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics
10.1074/mcp.m113.035600 · 2014 · External reference
Different potential of extracellular vesicles to support thrombin generation: contributions of phosphatidylserine, tissue factor, and cellular origin
10.1038/s41598-017-03262-2 · 2017 · External reference
KLF8 is activated by TGF-β1 via Smad2 and contributes to ovarian cancer progression
10.1002/jcb.30235 · ExternalCitation · doi-reference
Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches
10.1002/jev2.12404 · ExternalCitation · doi-reference
The role of Krüppel-like factor 8 in cancer biology: current research and its clinical relevance
10.1016/j.bcp.2020.114351 · ExternalCitation · doi-reference
The Krüppel-like factor (KLF) family, diseases, and physiological events
10.1016/j.gene.2023.148027 · ExternalCitation · doi-reference
Dysregulated pathways and potential biomarkers in dermatomyositis plasma-derived extracellular vesicles: a pilot study
10.1016/j.jid.2025.06.1597 · ExternalCitation · doi-reference
Tissue factor activity of small and large extracellular vesicles in different diseases
10.1016/j.rpth.2023.100124 · ExternalCitation · doi-reference
Extracellular vesicles as orchestrators of arterial and venous thrombosis: a unified mechanistic model
10.1016/j.vph.2026.107605 · ExternalCitation · doi-reference
Clinical and immunologic features of livedo reticularis in lupus: a case-control study
10.1016/s0002-9343(89)80823-x · ExternalCitation · doi-reference
Different potential of extracellular vesicles to support thrombin generation: contributions of phosphatidylserine, tissue factor, and cellular origin
10.1038/s41598-017-03262-2 · ExternalCitation · doi-reference
Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma
10.1038/s41598-018-35786-6 · ExternalCitation · doi-reference
KLF8 transcription factor participates in oncogenic transformation
10.1038/sj.onc.1209796 · ExternalCitation · doi-reference
Consensus on the management of the clinical challenges of venous thromboembolism in special situations
10.1055/a-2595-1811 · ExternalCitation · doi-reference
Extracellular vesicles in the antiphospholipid syndrome
10.1055/s-0037-1599081 · ExternalCitation · doi-reference
KLF11 protects against venous thrombosis via suppressing tissue factor expression
10.1055/s-0041-1735191 · ExternalCitation · doi-reference
Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics
10.1074/mcp.m113.035600 · ExternalCitation · doi-reference
Krüppel-like factors compete for promoters and enhancers to fine-tune transcription
10.1093/nar/gkx441 · ExternalCitation · doi-reference
Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion
10.1158/0008-5472.can-06-4729 · ExternalCitation · doi-reference
Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes
10.1161/01.atv.0000252898.48084.6a · ExternalCitation · doi-reference
Microparticles in hemostasis and thrombosis
10.1161/circresaha.110.233056 · ExternalCitation · doi-reference
Novel perspectives on extracellular vesicles in autoimmune diseases: immunogenicity, inflammation, and immune surveillance
10.1172/jci194715 · ExternalCitation · doi-reference
Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis
10.1177/09612033221126852 · ExternalCitation · doi-reference
Characterization of plasma-derived small extracellular vesicles indicates ongoing endothelial and platelet activation in patients with thrombotic antiphospholipid syndrome
10.3390/cells9051211 · ExternalCitation · doi-reference
Krüppel-like factor 8 overexpression is correlated with angiogenesis and poor prognosis in gastric cancer
10.3748/wjg.v19.i27.4309 · ExternalCitation · doi-reference
Regulation of vascular smooth muscle phenotype by cross-regulation of Krüppel-like factors
10.4196/kjpp.2017.21.1.37 · ExternalCitation · doi-reference
